Event JSON
{
"id": "0d3c9d4959a9653d2208351cdfc43f98883ac1858683530eba65631ae8d3390b",
"pubkey": "f261e77ed38c5a7c6cf34564b89b26bc002380ab3b4c2cab919e028030c393e7",
"created_at": 1731622838,
"kind": 1,
"tags": [
[
"r",
"https://www.foxnews.com/health/breast-cancer-vaccine-update-cleveland-clinic-new-era"
],
[
"subject",
"Breast cancer vaccine update from Cleveland Clinic: ‘A new era’"
],
[
"published_at",
"1731622461"
],
[
"image",
"https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/11/60/60/breast-cancer-vaccine-research-lab.jpg?ve=1\u0026tl=1"
],
[
"p",
"f261e77ed38c5a7c6cf34564b89b26bc002380ab3b4c2cab919e028030c393e7",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/11/60/60/breast-cancer-vaccine-research-lab.jpg?ve=1\u0026tl=1"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"The vaccine, which is the first to aim to prevent triple-negative breast cancer from developing, has shown promising results in a Phase 1 trial. The researchers found that the vaccine was generally well-tolerated and produced an immune response in most patients. The vaccine uses a protein found in breast tissue that is dedicated to lactation, called α-lactalbumin, which is no longer created after a woman is past childbearing age. This protein is expressed at high levels in more than 70% of triple-negative breast cancers, making it a potential target for the vaccine."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7fs7wlkn33d8cm8ng4jt3xexhsqz8q9t8dxze2u3ncpgqvxrj0ns8zan0k\nhttps://a57.foxnews.com/static.foxnews.com/foxnews.com/content/uploads/2024/11/60/60/breast-cancer-vaccine-research-lab.jpg?ve=1\u0026tl=1\nA breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.\nhttps://www.foxnews.com/health/breast-cancer-vaccine-update-cleveland-clinic-new-era",
"sig": "bbd09df994bd60ef875948654c95ede3a248b099082aa296a48b8a6c73e114023d1317002e1b359c3b9860ab65a477ad189810d4223df3fb9747d84c7fe1cb27"
}
